PT914148E - Tratamento do sindroma de insensibilidade parcial a hormona de crescimento - Google Patents
Tratamento do sindroma de insensibilidade parcial a hormona de crescimentoInfo
- Publication number
- PT914148E PT914148E PT97921307T PT97921307T PT914148E PT 914148 E PT914148 E PT 914148E PT 97921307 T PT97921307 T PT 97921307T PT 97921307 T PT97921307 T PT 97921307T PT 914148 E PT914148 E PT 914148E
- Authority
- PT
- Portugal
- Prior art keywords
- growth hormone
- syndrome
- patient
- igf
- partial
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- A61K38/22—Hormones
- A61K38/30—Insulin-like growth factors (Somatomedins), e.g. IGF-1, IGF-2
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- A61K38/22—Hormones
- A61K38/27—Growth hormone [GH] (Somatotropin)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P5/00—Drugs for disorders of the endocrine system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P5/00—Drugs for disorders of the endocrine system
- A61P5/06—Drugs for disorders of the endocrine system of the anterior pituitary hormones, e.g. TSH, ACTH, FSH, LH, PRL, GH
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- C07K14/575—Hormones
- C07K14/61—Growth hormones [GH] (Somatotropin)
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- C07K14/705—Receptors; Cell surface antigens; Cell surface determinants
- C07K14/72—Receptors; Cell surface antigens; Cell surface determinants for hormones
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US08/643,212 US6207640B1 (en) | 1994-04-07 | 1996-05-03 | Treatment of partial growth hormone insensitivity syndrome |
Publications (1)
Publication Number | Publication Date |
---|---|
PT914148E true PT914148E (pt) | 2003-12-31 |
Family
ID=24579841
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
PT97921307T PT914148E (pt) | 1996-05-03 | 1997-04-18 | Tratamento do sindroma de insensibilidade parcial a hormona de crescimento |
Country Status (10)
Country | Link |
---|---|
US (1) | US6207640B1 (pt) |
EP (2) | EP1369125A1 (pt) |
JP (1) | JP2001510444A (pt) |
AT (1) | ATE246511T1 (pt) |
CA (1) | CA2252560C (pt) |
DE (1) | DE69723982T2 (pt) |
DK (1) | DK0914148T3 (pt) |
ES (1) | ES2205211T3 (pt) |
PT (1) | PT914148E (pt) |
WO (1) | WO1997041887A1 (pt) |
Families Citing this family (8)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
EP1881005B1 (en) | 1997-07-14 | 2013-04-03 | Bolder Biotechnology, Inc. | Derivatives of G-CSF and related proteins |
US7495087B2 (en) | 1997-07-14 | 2009-02-24 | Bolder Biotechnology, Inc. | Cysteine muteins in the C-D loop of human interleukin-11 |
US20080076706A1 (en) | 1997-07-14 | 2008-03-27 | Bolder Biotechnology, Inc. | Derivatives of Growth Hormone and Related Proteins, and Methods of Use Thereof |
BR122013003013B8 (pt) * | 1999-01-14 | 2021-07-06 | Bolder Biotechnology Inc | proteína isolada monopeguilada do hormônio do crescimento e método para sua obtenção |
US8288126B2 (en) | 1999-01-14 | 2012-10-16 | Bolder Biotechnology, Inc. | Methods for making proteins containing free cysteine residues |
JP4237703B2 (ja) * | 2002-09-27 | 2009-03-11 | エフ.ホフマン−ラ ロシュ アーゲー | インスリン様成長因子結合タンパク質−4及びポリ(エチレングリコール)の接合体 |
DK2274978T3 (en) * | 2003-09-12 | 2015-06-15 | Ipsen Biopharmaceuticals Inc | Methods of treating an insulin-like growth factor-I (IGF-I) deficiency |
AU2010321225B2 (en) * | 2009-11-17 | 2015-12-03 | Ipsen Pharma S.A.S. | Formulation for hGH and rhIGF-1 combination |
Family Cites Families (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US5126324A (en) * | 1990-06-07 | 1992-06-30 | Genentech, Inc. | Method of enhancing growth in patients using combination therapy |
US5187151A (en) * | 1991-02-12 | 1993-02-16 | Genentech, Inc. | Use of binding protein with igf-i as an anabolic growth promoting agent |
US5824642A (en) * | 1994-04-07 | 1998-10-20 | Genentech, Inc. | Treatment of partial growth hormone insensitivity syndrome |
US5646113A (en) | 1994-04-07 | 1997-07-08 | Genentech, Inc. | Treatment of partial growth hormone insensitivity syndrome |
-
1996
- 1996-05-03 US US08/643,212 patent/US6207640B1/en not_active Expired - Lifetime
-
1997
- 1997-04-18 DK DK97921307T patent/DK0914148T3/da active
- 1997-04-18 DE DE69723982T patent/DE69723982T2/de not_active Expired - Lifetime
- 1997-04-18 EP EP03011410A patent/EP1369125A1/en not_active Ceased
- 1997-04-18 CA CA2252560A patent/CA2252560C/en not_active Expired - Lifetime
- 1997-04-18 EP EP97921307A patent/EP0914148B1/en not_active Expired - Lifetime
- 1997-04-18 ES ES97921307T patent/ES2205211T3/es not_active Expired - Lifetime
- 1997-04-18 PT PT97921307T patent/PT914148E/pt unknown
- 1997-04-18 JP JP53993897A patent/JP2001510444A/ja active Pending
- 1997-04-18 AT AT97921307T patent/ATE246511T1/de active
- 1997-04-18 WO PCT/US1997/006652 patent/WO1997041887A1/en active IP Right Grant
Also Published As
Publication number | Publication date |
---|---|
JP2001510444A (ja) | 2001-07-31 |
CA2252560C (en) | 2010-12-14 |
EP0914148A1 (en) | 1999-05-12 |
ES2205211T3 (es) | 2004-05-01 |
US6207640B1 (en) | 2001-03-27 |
WO1997041887A1 (en) | 1997-11-13 |
EP1369125A1 (en) | 2003-12-10 |
EP0914148B1 (en) | 2003-08-06 |
DE69723982D1 (de) | 2003-09-11 |
CA2252560A1 (en) | 1997-11-13 |
DE69723982T2 (de) | 2004-07-22 |
ATE246511T1 (de) | 2003-08-15 |
DK0914148T3 (da) | 2003-11-24 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
ES2160704T3 (es) | Tratamiento del sindrome de insensibilidad parcial a la hormona de crecimiento. | |
SE8703625D0 (sv) | New medical use | |
EP0476044A4 (en) | Treating disorders by application of insulin-like growth factors and analogs | |
EP0787802A3 (pt) | ||
NO940180D0 (no) | Anvendelse av IGF-I | |
JP2002536016A5 (pt) | ||
PT914148E (pt) | Tratamento do sindroma de insensibilidade parcial a hormona de crescimento | |
DE69635305D1 (de) | Verwendung eines anti-interleukin-9 antikörpers zur herstellung eines medikamentes zur behandlung von asthma | |
EP0515434A4 (en) | Method for treating intestinal diseases | |
DE69735883D1 (de) | Methode zur behandlung von muskelkrankheiten | |
HU9202092D0 (en) | An implantate composition containing biologically active protein, peptide or polypeptide | |
DE69326122D1 (de) | Verwendung von wachstumsfaktor igf-ii zur beahandlung von gastrointestinalen störungen | |
ATE251640T1 (de) | Neues chondrozytprotein | |
DE69113773D1 (de) | Verwendung von 3-aryl-5-alkylthio-4H-1,2,4-triazolen zur Behandlung von Überreflexen infolge von Rückenmarkstrauma. | |
BR9006746A (pt) | Peptideo fisiologicamente ativo e agente regulador do metabolismo de calcio | |
GB9120037D0 (en) | Immunological control of fat |